Multisystem inflammatory syndrome and COVID-19: a scoping review

Abstract Background: Multisystem inflammatory syndrome temporally associated with COVID-19 presents with similar symptomatology and therapeutic approach to Kawasaki disease in the pediatric population. Given the novelty of the disease and the growing scientific literature on the subject, it is relevant to collect and report available scientific information. This review aimed to explore the medical evidence on multisystem inflammatory syndrome temporally associated with COVID-19 in a population under 18 years of age. Methods: We conducted a scoping review using Scopus and PubMed, including observational (cohort, case-control, and cross-sectional) studies and case series Results: Of the total articles reviewed as of April 10, 2021, 45 articles met eligibility criteria: case series (n = 32), retrospective cohort studies (n = 6), prospective cohort studies (n = 4), case-control studies (n = 2), and cross-sectional studies (n = 1). Gastrointestinal and respiratory symptoms and myocardial dysfunction are the most commonly reported. The most relevant paraclinical markers were lymphopenia, thrombocytopenia, and elevated D-dimer levels Conclusions: The multisystem inflammatory syndrome temporally associated with COVID-19 presents a broad spectrum of signs and symptoms. Aneurysms of the coronary arteries and myocarditis are usually present in the acute phases of the disease. The early diagnosis led by a multidisciplinary group of pediatric intensivists, infectious disease specialists, cardiologists, and rheumatologists allows adequate and effective medical management.

Saved in:
Bibliographic Details
Main Authors: Tuta-Quintero,Eduardo, Martínez-Ayala,Camila, Mantilla-Beltrán,Gabriela, Rueda-Rodríguez,Alejandro, Pimentel,Juan
Format: Digital revista
Language:English
Published: Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez 2022
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462022000200069
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1665-11462022000200069
record_format ojs
spelling oai:scielo:S1665-114620220002000692022-04-26Multisystem inflammatory syndrome and COVID-19: a scoping reviewTuta-Quintero,EduardoMartínez-Ayala,CamilaMantilla-Beltrán,GabrielaRueda-Rodríguez,AlejandroPimentel,Juan Kawasaki Disease Vasculitis COVID-19 SARS-CoV-2 Systematic review Abstract Background: Multisystem inflammatory syndrome temporally associated with COVID-19 presents with similar symptomatology and therapeutic approach to Kawasaki disease in the pediatric population. Given the novelty of the disease and the growing scientific literature on the subject, it is relevant to collect and report available scientific information. This review aimed to explore the medical evidence on multisystem inflammatory syndrome temporally associated with COVID-19 in a population under 18 years of age. Methods: We conducted a scoping review using Scopus and PubMed, including observational (cohort, case-control, and cross-sectional) studies and case series Results: Of the total articles reviewed as of April 10, 2021, 45 articles met eligibility criteria: case series (n = 32), retrospective cohort studies (n = 6), prospective cohort studies (n = 4), case-control studies (n = 2), and cross-sectional studies (n = 1). Gastrointestinal and respiratory symptoms and myocardial dysfunction are the most commonly reported. The most relevant paraclinical markers were lymphopenia, thrombocytopenia, and elevated D-dimer levels Conclusions: The multisystem inflammatory syndrome temporally associated with COVID-19 presents a broad spectrum of signs and symptoms. Aneurysms of the coronary arteries and myocarditis are usually present in the acute phases of the disease. The early diagnosis led by a multidisciplinary group of pediatric intensivists, infectious disease specialists, cardiologists, and rheumatologists allows adequate and effective medical management.info:eu-repo/semantics/openAccessInstituto Nacional de Salud, Hospital Infantil de México Federico GómezBoletín médico del Hospital Infantil de México v.79 n.2 20222022-04-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462022000200069en10.24875/bmhim.21000073
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Tuta-Quintero,Eduardo
Martínez-Ayala,Camila
Mantilla-Beltrán,Gabriela
Rueda-Rodríguez,Alejandro
Pimentel,Juan
spellingShingle Tuta-Quintero,Eduardo
Martínez-Ayala,Camila
Mantilla-Beltrán,Gabriela
Rueda-Rodríguez,Alejandro
Pimentel,Juan
Multisystem inflammatory syndrome and COVID-19: a scoping review
author_facet Tuta-Quintero,Eduardo
Martínez-Ayala,Camila
Mantilla-Beltrán,Gabriela
Rueda-Rodríguez,Alejandro
Pimentel,Juan
author_sort Tuta-Quintero,Eduardo
title Multisystem inflammatory syndrome and COVID-19: a scoping review
title_short Multisystem inflammatory syndrome and COVID-19: a scoping review
title_full Multisystem inflammatory syndrome and COVID-19: a scoping review
title_fullStr Multisystem inflammatory syndrome and COVID-19: a scoping review
title_full_unstemmed Multisystem inflammatory syndrome and COVID-19: a scoping review
title_sort multisystem inflammatory syndrome and covid-19: a scoping review
description Abstract Background: Multisystem inflammatory syndrome temporally associated with COVID-19 presents with similar symptomatology and therapeutic approach to Kawasaki disease in the pediatric population. Given the novelty of the disease and the growing scientific literature on the subject, it is relevant to collect and report available scientific information. This review aimed to explore the medical evidence on multisystem inflammatory syndrome temporally associated with COVID-19 in a population under 18 years of age. Methods: We conducted a scoping review using Scopus and PubMed, including observational (cohort, case-control, and cross-sectional) studies and case series Results: Of the total articles reviewed as of April 10, 2021, 45 articles met eligibility criteria: case series (n = 32), retrospective cohort studies (n = 6), prospective cohort studies (n = 4), case-control studies (n = 2), and cross-sectional studies (n = 1). Gastrointestinal and respiratory symptoms and myocardial dysfunction are the most commonly reported. The most relevant paraclinical markers were lymphopenia, thrombocytopenia, and elevated D-dimer levels Conclusions: The multisystem inflammatory syndrome temporally associated with COVID-19 presents a broad spectrum of signs and symptoms. Aneurysms of the coronary arteries and myocarditis are usually present in the acute phases of the disease. The early diagnosis led by a multidisciplinary group of pediatric intensivists, infectious disease specialists, cardiologists, and rheumatologists allows adequate and effective medical management.
publisher Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez
publishDate 2022
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462022000200069
work_keys_str_mv AT tutaquinteroeduardo multisysteminflammatorysyndromeandcovid19ascopingreview
AT martinezayalacamila multisysteminflammatorysyndromeandcovid19ascopingreview
AT mantillabeltrangabriela multisysteminflammatorysyndromeandcovid19ascopingreview
AT ruedarodriguezalejandro multisysteminflammatorysyndromeandcovid19ascopingreview
AT pimenteljuan multisysteminflammatorysyndromeandcovid19ascopingreview
_version_ 1756227150820671489